![](data:image/svg+xml;charset=utf-8,<svg height="35px" width="135px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
FOUNDER
Dr.S.Devendra is a graduate in medicine. As Managing Director of Shasun Pharmaceuticals Limited, he was one of the key architects in developing Shasun on a global platform. He was instrumental in transforming Shasun from a domestic seller to an export-oriented Company exporting to the United States and several other countries. He has a wealth of knowledge in marketing, supply chain, licensing & human resources. He has gained a worldwide reputation for his knowledge in Customer Satisfaction, Global Competition, Strategic Thinking & Marketing.
COFOUNDER AND CEO
Mr. Jitesh has more than 21 years of experience in the Pharmaceutical space covering API and Formulations. He had the opportunity of leading a B2B as well as a B2C business. The core of his experience is B2B focused on Contract Development and Manufacturing plus Out licensing. Jitesh led the North America API business, as well as managed the Formulations P&L business of erstwhile Shasun Pharmaceuticals Limited, which later known as Strides Shasun and now Strides Pharma Science. His efforts have led the Division into new markets in North America; maintained business relationships and introduction of new Products for out-licensing and partnership. Post-Merger, Jitesh has been responsible for P&L business for North America, the United States and Europe Finished Dosage Form (Regulated Markets-Region 1) and overall responsible for API business P&L. Contract Development and Manufacturing plus Out licensing. Jitesh led the North America API business, as well as managed the Formulations P&L business of erstwhile Shasun Pharmaceuticals Limited, which later known as Strides Shasun and now Strides Pharma Science. His efforts have led the Division into new markets; maintained business relationships and introduction of new Products for out-licensing and partnership. Post-Merger, Jitesh has been responsible for P&L business for North America and Europe Finished Dosage Form (Regulated Markets-Region 1) and overall responsible for API business P&L.
DIRECTOR
Corporate finance executive over 35 years of experience in building, leading and advising corporations through restructuring, international expansion and corporate strategy. Strong in mergers and acquisition-International take over. Accomplished in structuring and negotiating favourable terms with FI and banks. Leadership approach to achieve improved financial performance, cost optimization and enhanced controls He has partnered across the business that led various projects like SAP implementations, Shared Services for global finance operations. Hari brings experience across Operations Improvements, Treasury, Investor relations, Strategy development and deployment, financial planning & analysis, secretarial and taxation. Hari is a qualified Cost Accountant AICWA (India) with 30+ years of managerial and professional experience. His last held position was as Executive Director Finance & CFO at Solara Active Pharma Sciences Limited. Prior to Solara, he worked in Strides Shasun, Reynolds ,UB Petro and Union Carbide.
ED & CSO
Dr. Sampathkumar Devarajan has 24+ years of Product Development Experience. He has worked in Indian Pharma Majors like Ranbaxy (Sun Pharma), Orchid, Panacea Biotec, Shasun, Strides Shasun and Lyrus. He has represented Shasun Pharmaceuticals Limited, in the capacity of Head – CMC for a face to face Pre-IND & Type C meetings with USFDA. He has also represented Shasun for face to face Scientific Advice meetings in the capacity of Head – CMC/Clinical with MHRA-UK, MPA-Sweden, AEMPS-Spain, Health Canada and MEB-Netherlands. He has successfully handled a couple of times United States Courts depositions as a part of Para IV –formulation and Para IV – Polymorph/formulation litigations. He is having inventership of 15 Patents/Patent applications and has 5 Research papers published in reputed journals. He has attended several National/International seminars, workshops and conferences across the United States, Europe and elsewhere.
EXECUTIVE DIRECTOR OPERATIONS
Sreeni has over 27 years of experience in Pharmaceutical Finish Dosage Forms and Active Pharma Ingredients industry at various disciplines of Manufacturing, Technology Transfer, Project Management in setting up facilities, Quality Assurance, Plant operations and Sales & Marketing. Sreeni did his Master of Pharmacy in Pharmaceutical Management from College of Pharmaceutical Sciences, KMC, Manipal specialized in Industrial Pharmacy. Sreeni worked with Dr. Reddys, Strides Pharmaceuticals, Murty Pharma Inc, Medreich, Caplin Point,Shasun Pharmaceuticals, Strides Shasun and Solara Active Pharma Sciences Limited. Sreeni’s last assignment in Solara, a Pure Play API manufacturing company as Chief Operating Officer. Sreeni is specialized in Energy Conservation and optimization of operating cost in Pharma industries under the guidance of Tata Energy and Research Institute. His major experience in Finish Dosage Forms as auditee and head of manufacturing plants. As head of manufacturing plants Sreeni has successfully handled several regulatory inspections such as USFDA, TGA, MHRA, WHO including other regulatory agencies in his career.
CHIEF FINANCIAL OFFICER
P Harihara Ponnambalam is a Chartered Accountant having 16 years of experience in the field of Financial Planning & Analysis, Taxation, Treasury, Finance and Accounts. He also had an international assignment with rich experience to International Taxation and Treasury. Prior to Joining Axxelent, he had extensive experience in the Auto ancillary and Pharma Sectors and worked in a renowned organization like HCL Infosystems Limited, Sundaram Clayton Limited, Shasun Pharmaceuticals Limited and ZF WABCO. He also served as a CFO of Caplin Point laboratory Limited.
Headquartered in Chennai, India, Axxelent is focused on Contract Development of Oral Solid Dosage, Injectables, Ophthalmic, Oral Liquids and Topicals and Manufacturing of Oral Solid Dosage, Oral Liquids and Topicals (Block-1) and Injectables & Ophthalmic (Block-2), for markets across the world including Europe and North America.
CIN : U24110TN2019PTC131943
Axxelent Pharma Science Pvt. Ltd., Module No.1, 10th Floor
A Block, IIT Madras Research Park, Kanagam Road, Taramani, Chennai-600113.
Tamil Nadu, India.
Call Us On : +91-44-61727900
Email Us : info@axxelent.com
SEZ UNIT No.910, Portia Road, Sri City, Tirupati District,
Andhra Pradesh, 517646.
Andhra Pradesh, India.
Call Us On : +91 8576 691100
Email Us : info@axxelent.com
3 Jagadeeswaran Street
T.Nagar
Chennai-600017, India.
Call Us On : 044-69127900
Email Us : info@axxelent.com
Expansion of Phase 2 Manufacturing for Small Volume Parenteral“Axxelent R&D unit received Recognition letter & Registration Certificate from DSIR, Ministry of Science and Technology, Govt. of India”